Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study - Individual Prediction and Prevention of Risks of Immunosuppressive Therapies in Transplantation Access content directly
Journal Articles Clinics and Research in Hepatology and Gastroenterology Year : 2021

Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study

Mohamed Hebbar
  • Function : Author

Domains

Cancer
Fichier principal
Vignette du fichier
S2210740120301571.pdf (625.04 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04548045 , version 1 (22-07-2024)

Licence

Identifiers

Cite

Anthony Turpin, Thierry de Baere, Alexandra Heurgué, Karine Le Malicot, Isabelle Ollivier-Hourmand, et al.. Liver transarterial chemoembolization and sunitinib for unresectable hepatocellular carcinoma: Results of the PRODIGE 16 study. Clinics and Research in Hepatology and Gastroenterology, 2021, 45 (2), pp.101464. ⟨10.1016/j.clinre.2020.05.012⟩. ⟨hal-04548045⟩
17 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More